Multiple Cancer Drug Approvals Highlights SPT Week in Review

Article

Top news of the week from Specialty Pharmacy Times.

5. Lifetime Sun Exposure May Reduce Multiple Sclerosis Risk

Individuals who experience high sun exposure during childhood or young adulthood may be less likely to develop multiple sclerosis. Read more.

4. Erdafitinib Gains FDA Breakthrough Designation for Urothelial Cancer

Pan-fibroblast growth factor receptor tyrosine kinase inhibitor demonstrates efficacy in urothelial cancer. Read more.

3. FDA Approves Novel Biologic for Plaque Psoriasis

Tildrakizumab-asmn (Ilumya) approved for the treatment of moderate-to-severe plaque psoriasis. Read more.

2. FDA Greenlights Adcetris as First-line Combination Therapy for Classical Hodgkin Lymphoma

Brentuximab vedotin (Adcetris) plus chemotherapy may lead to better disease outcomes for patients with classical Hodgkin lymphoma. Read more.

1. Nilotinib Approved to Treat Pediatric Patients with Leukemia

Nilotinib (Tasigna) was previously granted priority review for the treatment of pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia. Read more.

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.